WayPoint Biomedical Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WYPH research report →
Companywww.waypointbiomedical.com
WayPoint Biomedical Holdings, Inc. , through its wholly owned subsidiary, WayPoint Biomedical, Inc. , engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment.
- CEO
- Steven Fox
- IPO
- 2015
- HQ
- Huntington Beach, CA, US
Price Chart
Valuation
- Market Cap
- $13.30K
- P/E
- -0.33
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-44,976 · 0.00%
- EPS
- $-0.00 · 0.00%
- Op Income
- $-44,976
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -8.36
- Avg Volume
- 640
Get TickerSpark's AI analysis on WYPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our WYPH Coverage
We haven't published any research on WYPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate WYPH Report →